Portal de Periódicos da CAPES

Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine

2017; Elsevier BV; Volume: 21; Issue: 2 Linguagem: Francês

10.1016/j.canrad.2016.10.003

1769-6658

Ariane Lapierre, O. Riou, Aude Fléchon, Nicolas Mottet, D. Azria,

Urological Disorders and Treatments

Penile cancer is a rare entity with only 2000 new cases a year in the United States. Even though early stage penile cancer has an excellent prognosis, patients with positive pelvic lymph nodes have an overall 5-year survival rate under 10%. There is no consensus for the management of pelvic node-positive patients, although most guidelines are in favour of pelvic lymph node dissection for patients with two or more positive nodes, followed by adjuvant chemotherapy. We describe here the case of a patient with numerous metastatic lymph nodes at diagnosis, treated with chemoradiation (66Gy with concurrent gemcitabine) after failure of first-line chemotherapy and still alive and disease-free 7 years after diagnosis.